Related Experiment Video

Updated: Jul 14, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Myocardial revascularization: surgery or stenting?

Sunny H Wong1, Song Wan, Malcolm J Underwood

  • 1Division of Cardiothoracic Surgery, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.

Asian Cardiovascular & Thoracic Annals
|June 2, 2007
PubMed

Insights

Surgical revascularization and percutaneous revascularization offer distinct benefits for obstructive coronary artery disease. This review examines current literature to clarify their respective roles and advantages.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Obstructive coronary artery disease (CAD) remains a leading cause of morbidity and mortality worldwide.
  • Treatment strategies for CAD include medical management, percutaneous coronary intervention (PCI), and coronary artery bypass grafting (CABG).
  • Ongoing debate exists regarding the optimal revascularization strategy for specific patient subgroups.

Purpose of the Study:

  • To critically review and synthesize the current evidence comparing surgical revascularization and percutaneous revascularization in patients with obstructive coronary artery disease.
  • To delineate the relative merits, indications, and outcomes associated with each revascularization modality.
  • To provide insights into the evolving therapeutic landscape for managing complex CAD.

Main Methods:

  • Comprehensive literature search of major biomedical databases (e.g., PubMed, Embase, Cochrane Library).
  • Inclusion of randomized controlled trials, meta-analyses, and observational studies published within the last 10 years.
  • Focus on studies reporting clinical outcomes, procedural success rates, and long-term follow-up.

Main Results:

  • Percutaneous revascularization, particularly with drug-eluting stents, demonstrates comparable short-term efficacy to surgical revascularization in stable ischemic heart disease.
  • Surgical revascularization often shows superior long-term outcomes, especially in patients with multi-vessel disease, diabetes mellitus, or reduced left ventricular function.
  • Complex anatomical factors and patient comorbidities significantly influence the choice between surgical and percutaneous approaches.

Conclusions:

  • The selection of revascularization strategy should be individualized based on patient-specific factors, including coronary anatomy, comorbidities, and patient preference.
  • Both surgical and percutaneous revascularization have well-defined roles in the management of obstructive coronary artery disease.
  • Multidisciplinary heart team discussion is crucial for optimizing treatment decisions in complex CAD cases.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...